Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Tumor necrosis factor-alpha is a marker of familial combined hyperlipidemia, independently of metabolic syndrome.

Pauciullo P, Gentile M, Marotta G, Baiano A, Ubaldi S, Jossa F, Iannuzzo G, Faccenda F, Panico S, Rubba P.

Metabolism. 2008 Apr;57(4):563-8. doi: 10.1016/j.metabol.2007.11.021.

PMID:
18328361
2.

Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events.

Pauciullo P, Gentile M, Marotta G, Baiano A, Ubaldi S, Jossa F, Iannuzzo G, Faccenda F, Panico S, Rubba P.

Atherosclerosis. 2009 Mar;203(1):320-4. doi: 10.1016/j.atherosclerosis.2008.07.004. Epub 2008 Jul 12.

PMID:
18760784
3.

Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly.

Abbatecola AM, Ferrucci L, Grella R, Bandinelli S, Bonafè M, Barbieri M, Corsi AM, Lauretani F, Franceschi C, Paolisso G.

J Am Geriatr Soc. 2004 Mar;52(3):399-404.

PMID:
14962155
4.

Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects.

Kim YC, Cho YK, Lee WY, Kim HJ, Park JH, Park DI, Sohn CI, Jeon WK, Kim BI, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Ryu SH.

J Nutr Biochem. 2011 Mar;22(3):289-92. doi: 10.1016/j.jnutbio.2010.02.007. Epub 2010 Jun 25.

PMID:
20579864
5.

[Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia].

Pei WD, Sun YH, Rou WJ, Zu Q, Li Y, Zhang CY, Dai J, Jia YH, Lu ZL, Wu XG, Liu LS, Hui RT.

Zhonghua Yi Xue Za Zhi. 2005 Feb 2;85(5):313-7. Chinese.

PMID:
15854507
6.

Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia.

Pei WD, Sun YH, Lu B, Liu Q, Zhang CY, Zhang J, Jia YH, Lu ZL, Hui RT, Liu LS, Yang YJ.

Int J Cardiol. 2007 Mar 20;116(2):194-200. Epub 2006 Jul 10.

PMID:
16828905
7.

Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-alpha in a general population.

Yamagishi S, Adachi H, Matsui T, Nakamura K, Enomoto M, Fukami A, Otsuka M, Kumagae S, Nanjo Y, Imaizumi T.

Clin Cardiol. 2009 Sep;32(9):E29-32. doi: 10.1002/clc.20517.

8.

The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation.

Gençtoy G, Kahraman S, Arici M, Altun B, Erdem Y, Bakkaloğlu M, Yasavul U, Turgan C.

Transplant Proc. 2006 Mar;38(2):521-8.

PMID:
16549165
9.
10.

Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron.

Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokić E.

Intern Med. 2007;46(13):945-51. Epub 2007 Jul 2.

11.

Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men.

Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, Sugiura K, Kondo T, Murohara T, Toyoshima H.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):871-6. Epub 2006 Feb 2.

12.

Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.

Bautista LE, Vera LM, Arenas IA, Gamarra G.

J Hum Hypertens. 2005 Feb;19(2):149-54.

PMID:
15361891
13.

Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.

Hsu LA, Ko YL, Wu S, Teng MS, Chou HH, Chang CJ, Chang PY.

Metabolism. 2009 Jul;58(7):983-8. doi: 10.1016/j.metabol.2009.02.021.

PMID:
19394054
14.
15.

Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity.

Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M.

Metab Syndr Relat Disord. 2009 Oct;7(5):447-52. doi: 10.1089/met.2008.0100.

PMID:
19419266
16.

Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan.

Chou YY, Sheu WH, Tang YJ, Chen YM, Liao SC, Chuang YW, Lin CS, Chen DY.

Arch Gerontol Geriatr. 2009 Dec;49 Suppl 2:S41-5. doi: 10.1016/S0167-4943(09)70012-3.

PMID:
20005426
17.

Association of free fatty acids (FFA) and tumor necrosis factor-alpha (TNF-alpha) and insulin-resistant metabolic disorder.

Ohmura E, Hosaka D, Yazawa M, Tsuchida A, Tokunaga M, Ishida H, Minagawa S, Matsuda A, Imai Y, Kawazu S, Sato T.

Horm Metab Res. 2007 Mar;39(3):212-7.

PMID:
17373637
18.

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.

Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A, Hellénius ML, Fisher RM.

Eur Heart J. 2007 Nov;28(21):2637-43. Epub 2007 Sep 1.

PMID:
17766927
19.

C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia.

Bo S, Signorile A, Menato G, Gambino R, Bardelli C, Gallo ML, Cassader M, Massobrio M, Pagano GF.

J Endocrinol Invest. 2005 Oct;28(9):779-86.

PMID:
16370555
20.

Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.

Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S, Djuric I, Ristic D.

Ren Fail. 2007;29(3):321-9.

PMID:
17497447

Supplemental Content

Support Center